ArticleFrontiers in cardiovascular medicine2026
Living with angina: rethinking angina management in ANOCA through lived experience.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Angina with non-obstructive coronary arteries (ANOCA) is an important cause of chronic angina and reduced quality of life. Despite advances in diagnostic testing and growing recognition of coronary vasomotor disorders, many of those living with ANOCA continue to experience ongoing symptoms despite treatment. The existing literature largely focuses on diagnostic methods and pharmacological management, while comparatively little attention has been paid to the lived experience of symptom control. The objective of this perspective paper, produced with the co-founders of the International Heart Spasms Alliance, is to explore angina management in ANOCA through the lens of lived experience and patient advocacy. Key challenges include the substantial impact of chronic angina on daily life, difficulties identifying effective therapies, the need to adapt to a new normal, reliance on self-management strategies, uncertainty surrounding acute symptom escalation, and the importance of support and validation. Improved angina management in ANOCA requires a holistic and individualised approach that combines mechanism-based treatment, multidisciplinary support, and meaningful incorporation of lived perspectives into clinical care and research. Successful angina management should be measured not only by symptom reduction, but also by improvements in quality of life and overall wellbeing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.